← Back to Search

Oxytocic Agent

Oxytocin 1IU for Postpartum Hemorrhage

N/A
Waitlist Available
Led By Mrinalini Balki, MD
Research Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI≥40 kg/m2
Elective cesarean delivery under spinal, epidural, or combined spinal-epidural anaesthesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial is testing whether carbetocin is non-inferior to oxytocin for reducing postpartum hemorrhage in obese women.

Eligible Conditions
  • Postpartum Hemorrhage

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uterine Tone 3 minutes
Secondary outcome measures
Additional uterotonics - 24 hours
Additional uterotonics - Post Anesthesia Care Unit (PACU)
Additional uterotonics - operating room
+17 more

Trial Design

2Treatment groups
Active Control
Group I: Oxytocin 1IUActive Control1 Intervention
Oxytocin 1IU, administered intravenously over 1 minute, immediately upon delivery of the anterior shoulder of the baby, followed by infusion 80 mU/min (40 IU in 1L given at a rate of 120 mL/h).
Group II: Carbetocin 80mcgActive Control1 Intervention
Carbetocin 80mcg, administered intravenously over 1 minute, immediately upon delivery of the anterior shoulder of the baby.

Find a Location

Who is running the clinical trial?

Samuel Lunenfeld Research Institute, Mount Sinai HospitalLead Sponsor
123 Previous Clinical Trials
10,909 Total Patients Enrolled
29 Trials studying Postpartum Hemorrhage
1,517 Patients Enrolled for Postpartum Hemorrhage
Mrinalini Balki, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL
28 Previous Clinical Trials
1,771 Total Patients Enrolled
21 Trials studying Postpartum Hemorrhage
1,047 Patients Enrolled for Postpartum Hemorrhage

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~13 spots leftby Mar 2025